• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll样受体在急性淋巴细胞白血病自然杀伤细胞功能中的作用

Role of Toll-like receptors in natural killer cell function in acute lymphoblastic leukemia.

作者信息

Gallardo-Zapata Janet, Maldonado-Bernal Carmen

机构信息

Immunology and Proteomics Research Unit, Children's Hospital of Mexico Federico Gómez, Mexico City 06720, Mexico.

Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.

出版信息

Oncol Lett. 2021 Nov;22(5):748. doi: 10.3892/ol.2021.13009. Epub 2021 Aug 24.

DOI:10.3892/ol.2021.13009
PMID:34539852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8436356/
Abstract

Natural killer (NK) cells are specialized lymphocytes primarily involved in the response to infection and tumors. NK cells are characterized by the presence of specific surface molecules, as well as a wide repertoire of receptors that impart microenvironment-dependent effector functions. Among these receptors, Toll-like receptors (TLRs) can be activated to condition the NK response to either a cytotoxic or immunoregulatory phenotype. However, cellular function is frequently impaired during disorders such as cancer. In the last decade, it has become increasingly evident that the stimulation of NK cells is a requirement for their increased cytotoxic activity. TLR activation has been suggested as an alternative route for reestablishing the antitumor activity of NK cells. The present review summarizes the characteristics of NK cells, their receptors, the expression and function of NK cell TLRs, and their functional status in cancer, primarily acute lymphoblastic leukemia.

摘要

自然杀伤(NK)细胞是一类特殊的淋巴细胞,主要参与对感染和肿瘤的反应。NK细胞的特征是存在特定的表面分子,以及具有广泛的受体,这些受体赋予其依赖微环境的效应功能。在这些受体中,Toll样受体(TLR)可被激活,从而使NK细胞的反应转变为细胞毒性或免疫调节表型。然而,在癌症等疾病中,细胞功能常常受损。在过去十年中,越来越明显的是,刺激NK细胞是增强其细胞毒性活性的必要条件。TLR激活已被认为是恢复NK细胞抗肿瘤活性的一条替代途径。本综述总结了NK细胞的特征、其受体、NK细胞TLR的表达和功能,以及它们在癌症(主要是急性淋巴细胞白血病)中的功能状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f713/8436356/f708a8b174c3/ol-22-05-13009-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f713/8436356/c555de1a81f5/ol-22-05-13009-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f713/8436356/dd8e6349a0f2/ol-22-05-13009-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f713/8436356/8d7837b2e853/ol-22-05-13009-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f713/8436356/f708a8b174c3/ol-22-05-13009-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f713/8436356/c555de1a81f5/ol-22-05-13009-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f713/8436356/dd8e6349a0f2/ol-22-05-13009-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f713/8436356/8d7837b2e853/ol-22-05-13009-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f713/8436356/f708a8b174c3/ol-22-05-13009-g03.jpg

相似文献

1
Role of Toll-like receptors in natural killer cell function in acute lymphoblastic leukemia.Toll样受体在急性淋巴细胞白血病自然杀伤细胞功能中的作用
Oncol Lett. 2021 Nov;22(5):748. doi: 10.3892/ol.2021.13009. Epub 2021 Aug 24.
2
TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.浆细胞样树突状细胞激活的自然杀伤细胞通过TRAIL介导杀伤急性淋巴细胞白血病细胞
Oncotarget. 2015 Oct 6;6(30):29440-55. doi: 10.18632/oncotarget.4984.
3
NK Cell Subpopulation Is Altered and the Expression of TLR1 and TLR9 Is Decreased in Patients with Acute Lymphoblastic Leukemia.急性淋巴细胞白血病患者的NK细胞亚群发生改变,且Toll样受体1(TLR1)和Toll样受体9(TLR9)的表达降低。
J Oncol. 2021 Sep 15;2021:5528378. doi: 10.1155/2021/5528378. eCollection 2021.
4
TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.Toll样受体7/8介导的人类自然杀伤细胞激活导致辅助细胞依赖性γ干扰素产生。
J Immunol. 2005 Aug 1;175(3):1636-42. doi: 10.4049/jimmunol.175.3.1636.
5
Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity.低危急性淋巴细胞白血病患者来源的间充质干细胞促进 NK 细胞抗肿瘤活性。
Cancer Lett. 2015 Jul 28;363(2):156-65. doi: 10.1016/j.canlet.2015.04.012. Epub 2015 Apr 23.
6
Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia.MLL-AF9诱导的急性髓系白血病中白血病微环境来源自然杀伤细胞的特征
Mol Immunol. 2018 Jan;93:68-78. doi: 10.1016/j.molimm.2017.11.003. Epub 2017 Nov 16.
7
Determining Endosomal Toll-Like Receptors Gene Expression in NK Cells After Stimulation with Specific Agonists.鉴定 NK 细胞在受到特定激动剂刺激后内体 Toll 样受体基因的表达。
Methods Mol Biol. 2023;2700:151-162. doi: 10.1007/978-1-0716-3366-3_8.
8
Establishment and characterization of SRIK-NKL: a novel CD8+ natural killer/T cell line derived from a patient with leukemic phase of acute lymphoblastic lymphoma.
Leuk Res. 2005 Jul;29(7):771-83. doi: 10.1016/j.leukres.2004.12.017.
9
Bovine colostrum enhances natural killer cell activity and immune response in a mouse model of influenza infection and mediates intestinal immunity through toll-like receptors 2 and 4.牛初乳可增强流感感染小鼠模型中的自然杀伤细胞活性和免疫反应,并通过Toll样受体2和4介导肠道免疫。
Nutr Res. 2014 Apr;34(4):318-25. doi: 10.1016/j.nutres.2014.02.007. Epub 2014 Mar 6.
10
Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.心理压力水平高的乳腺癌患者自然杀伤细胞杀伤功能受损与杀伤免疫球蛋白样受体表达改变有关。
J Surg Res. 2007 May 1;139(1):36-44. doi: 10.1016/j.jss.2006.08.037. Epub 2007 Feb 9.

引用本文的文献

1
The innate defenders: a review of natural killer cell immunotherapies in cancer.先天性防御者:癌症中自然杀伤细胞免疫疗法综述
Front Immunol. 2024 Dec 23;15:1482807. doi: 10.3389/fimmu.2024.1482807. eCollection 2024.
2
Different infant formulas can activate toll-like receptor 9 in vitro and inhibit interleukin 6 in human primary intestinal epithelial cells.不同的婴儿配方奶粉可以在体外激活 Toll 样受体 9,并抑制人原代肠道上皮细胞中的白细胞介素 6。
Eur J Nutr. 2024 Nov 21;64(1):16. doi: 10.1007/s00394-024-03507-7.
3
Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.

本文引用的文献

1
CAR-NK cells: A promising cellular immunotherapy for cancer.嵌合抗原受体自然杀伤细胞:癌症有前途的细胞免疫疗法。
EBioMedicine. 2020 Sep;59:102975. doi: 10.1016/j.ebiom.2020.102975. Epub 2020 Aug 24.
2
TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy.TLR7/8 激动剂负载纳米颗粒增强 NK 细胞介导的基于抗体的癌症免疫疗法。
Mol Pharm. 2020 Jun 1;17(6):2109-2124. doi: 10.1021/acs.molpharmaceut.0c00271. Epub 2020 May 21.
3
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
芦可替尼并没有完全消除 TLR4/9 配体激活的 NK 细胞的功能能力。
Front Immunol. 2023 Jan 5;13:1045316. doi: 10.3389/fimmu.2022.1045316. eCollection 2022.
嵌合抗原受体修饰的自然杀伤细胞在 CD19 阳性淋巴肿瘤中的应用。
N Engl J Med. 2020 Feb 6;382(6):545-553. doi: 10.1056/NEJMoa1910607.
4
Functional characterization of NK cells in Mexican pediatric patients with acute lymphoblastic leukemia: Report from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia.墨西哥儿科急性淋巴细胞白血病患儿 NK 细胞功能特征:来自墨西哥机构间儿童白血病病因识别小组的报告。
PLoS One. 2020 Jan 17;15(1):e0227314. doi: 10.1371/journal.pone.0227314. eCollection 2020.
5
The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study.Toll样受体9激动剂(GNKG168)在微小残留病阳性的儿童急性白血病患者体内诱导出独特的免疫激活模式:TACL T2009 - 008 I期研究结果
Pediatr Hematol Oncol. 2019 Nov;36(8):468-481. doi: 10.1080/08880018.2019.1667461. Epub 2019 Sep 18.
6
Human natural killer cells mediate adaptive immunity to viral antigens.人类自然杀伤细胞介导对病毒抗原的适应性免疫。
Sci Immunol. 2019 May 10;4(35). doi: 10.1126/sciimmunol.aat8116.
7
Targeting natural killer cells in solid tumors.针对实体瘤中的自然杀伤细胞。
Cell Mol Immunol. 2019 May;16(5):415-422. doi: 10.1038/s41423-019-0224-2. Epub 2019 Mar 25.
8
The TLR3 Agonist Poly Inosinic:Cytidylic Acid Significantly Augments the Therapeutic Activity of an Anti-CD7 Immunotoxin for Human T-cell Leukaemia.Toll样受体3激动剂聚肌苷酸:胞苷酸显著增强抗CD7免疫毒素对人T细胞白血病的治疗活性。
Biomedicines. 2019 Feb 16;7(1):13. doi: 10.3390/biomedicines7010013.
9
NKG2A Down-Regulation by Dasatinib Enhances Natural Killer Cytotoxicity and Accelerates Effective Treatment Responses in Patients With Chronic Myeloid Leukemia.达沙替尼下调 NKG2A 增强慢性髓系白血病患者自然杀伤细胞的细胞毒性并加速有效治疗反应。
Front Immunol. 2019 Jan 17;9:3152. doi: 10.3389/fimmu.2018.03152. eCollection 2018.
10
Natural Killer Cells: Development, Maturation, and Clinical Utilization.自然杀伤细胞:发育、成熟与临床应用。
Front Immunol. 2018 Aug 13;9:1869. doi: 10.3389/fimmu.2018.01869. eCollection 2018.